MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
58.51
+1.96 (3.47%)
Oct 2, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $2.82 billion as of October 2, 2026. Its market cap has increased by 252.05% in one year.
Market Cap
2.82B
Enterprise Value
2.40B
1-Year Change
252.05%
Ranking
Category
Stock Price
$58.51
ChartMarket Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $2.82B, an increase of 452.89%. That is a compound annual growth rate of 130.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 2.82B | 98.97% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 3.21B |
| Arcutis Biotherapeutics | 3.18B |
| Dyne Therapeutics | 2.95B |
| Precigen | 2.94B |
| NewAmsterdam Pharma Company | 2.89B |
| Zai Lab | 2.86B |
| Celldex Therapeutics | 2.53B |
| Disc Medicine | 2.44B |